STOCK-BASED COMPENSATION. (Details 1) |
12 Months Ended |
|---|---|
|
Dec. 31, 2017
$ / shares
shares
| |
| $12.90 | |
| Number Outstanding | shares | 11,000 |
| Weighted Average Remaining Contractual Life (yrs) | 3 years 7 months 2 days |
| Weighted Average Exercise Price | $ / shares | $ 12.90 |
| Number Exercisable | shares | 11,000 |
| Weighted Average Exercise Price | $ / shares | $ 12.90 |
| $3.74 | |
| Number Outstanding | shares | 219,000 |
| Weighted Average Remaining Contractual Life (yrs) | 5 years 5 months 19 days |
| Weighted Average Exercise Price | $ / shares | $ 3.74 |
| Number Exercisable | shares | 219,000 |
| Weighted Average Exercise Price | $ / shares | $ 3.74 |
| X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|